Steroid bills
This article was originally published in The Tan Sheet
Executive Summary
House Government Reform Committee Chairman Tom Davis (R-Va.) will introduce a bill the week of May 23 proposing a uniform drug testing policy for major professional sports leagues, including MLB, the NFL and the NBA. Co-authored by Rep. Henry Waxman (D-Calif.) and Sen. John McCain (R-Ariz.), the legislation likely will suggest similar penalties to Rep. Cliff Stearns' (R-Fla.) Drug Free Sports Act, which calls for minimum two-year bans for first offenses and lifetime bans for second offenses. The House Government Reform Committee held a hearing on the NBA's drug policy on the heels of an NFL meeting in April (1"The Tan Sheet" May 2, 2005, p. 14)...
You may also be interested in...
NFL Supplement Policy Not Hindered By Lack Of GMPs – Tagliabue
The absence of dietary supplement good manufacturing practices has had minimal impact on the National Football League's steroid policy, according to Commissioner Paul Tagliabue
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.